STEPHANIE BEYES: Open Payments
NPI 1740948249 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 39 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $4,321 · 2025 $1,036
Food & beverage: $937Education: $99
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $295 |
| Eisai Inc. | 5 | $109 |
| SEAGEN INC. | 1 | $99 |
| AstraZeneca Pharmaceuticals LP | 6 | $92 |
| GlaxoSmithKline, LLC. | 1 | $86 |
| Astellas Pharma US Inc | 3 | $69 |
| ABBVIE INC. | 3 | $67 |
| Daiichi Sankyo Inc. | 2 | $57 |
| Genmab U.S., Inc. | 2 | $51 |
| Tempus AI, Inc | 2 | $33 |
Products named: KEYTRUDA, Lenvima, LYNPARZA, ENHERTU, Veozah, ELAHERE, Tivdak, XT CDX.
Industry payments across NM — which companies pay providers there.
